Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Neuropeptide Y and Calcium Supplement

Research Papers that Mention the Interaction

In different types of neurone, activation of ~-adrenergic, GABAB, adenosine A~, dopamine, 5-HT,/~, 6and x-opioid, muscarinic acetylcholine, neuropeptide Y and somatostatin receptors results in inhibition of Ca 2÷ currents (for review see Tsien et al., 1988).
General pharmacology  •  1989  |  View Paper
NPY induced an intracellular calcium increase mainly mediated by Y2 and Y5 receptors in basal conditions.
Regulatory peptides  •  2003  |  View Paper
In the presence of nifedipine (1 μM), whole-cell outward currents through Ca2+ -activated K+ channels were inhibited by NPY in a dose-dependent manner from 20 to 200 nM. A maximum inhibition to about 48% of the control current could be achieved.
Pflügers Archiv  •  2004  |  View Paper
These results suggest that NPY may potentiate vasoconstriction by promoting calcium entry through L-type voltage-dependent Ca2+-channels.
Pflügers Archiv  •  2004  |  View Paper
NPY inhibits the stimulated secretion of CAs, however, its role in regulation of the genes encoding CA biosynthetic enzymes is not clear.
We conclude that NPY stimulates the CA biosynthetic pathway in the adrenal medulla and positive auto-regulation of NPY might be involved in this process.
Neuropharmacology  •  2002  |  View Paper
CA inhibited both basal and FOR + PMA induced production of NPY and DNA synthesis in a dose‐dependent manner: at 6 μM CA, basal NPY production was reduced by about 50%, FOR + PMA stimulated production of NPY and DNA synthesis were completely inhibited, and astrocytes were essentially eliminated.
Journal of neuroscience research  •  1994  |  View Paper
The results suggested that NPY was co-released with CAs from chromaffin cells and then acted as a modulator on CA secretion.
Neurochemistry International  •  1993  |  View Paper
6 The results show that, in rat mesenteric arterioles, NPY potentiates only the calcium entry blocker‐sensitive component of contraction induced by stimulation of α1‐adrenoceptors.
It is suggested that NPY enhances calcium entry induced by stimulation of α1‐adrenoceptors in this tissue.
British journal of pharmacology  •  1990  |  View Paper
Both NPY and the specific Y1 receptor ligand, [Leu31,Pro34]‐NPY, caused a rapid and transient increase in the concentration of free calcium in the cytoplasm as measured by the fluorescent probe, Fura‐2.
FEBS letters  •  1990  |  View Paper
It is hypothesized that NPY increases the early (phasic) component of the contractile response by preferentially influencing release of intracellular calcium stores.
The Journal of pharmacology and experimental therapeutics  •  1989  |  View Paper
Show More